scholarly journals Panel Discussion: Current Status of Measuring Sleepiness

2011 ◽  
Vol 7 (5 Suppl) ◽  
Author(s):  
Janet M. Mullington ◽  
Charles A. Czeisler ◽  
Namni Goel ◽  
James M. Krueger ◽  
Thomas J. Balkin ◽  
...  
Keyword(s):  
Panel Discussion ◽  
Current Status

Panel discussion: Current status of plastics for optics

1980 ◽  
Author(s):  
Gary W. Wilkerson ◽  
Brian Welham ◽  
Joseph E. Berg ◽  
John D. Lytle ◽  
Robert W. Jans ◽  
...  
Keyword(s):  
Panel Discussion ◽  
Current Status

3rd Colombian educational workshop on regulatory assessment of biosimilars 2019 – Report

2020 ◽  
Vol 9 (3) ◽  
pp. 132-144
Author(s):  
John-Joseph Borg ◽  
Yolanda Elias Gramajo ◽  
Andrea Laslop ◽  
Robin Thorpe ◽  
Jian Wang
Keyword(s):  
Best Practice ◽  
Panel Discussion ◽  
Access To Medicines ◽  
Current Status ◽  
Regulatory Guidelines ◽  
The Us ◽  
Regulatory Assessment ◽  
Educational Workshop

Introduction: Biosimilars have the potential to improve access to medicines for many across the globe. However, work is required to ensure adequate regulation, pharmacovigilance and education about biosimilars. Colombia implemented biosimilars regulation in 2017 and a 3rd Colombian Educational Workshop was organized by GaBI and the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) in 2019 to follow up on progress and provide a forum for further discussion. Methods: The 3rd Colombian Educational Workshop on Regulatory Assessment was held in Bogotá, Colombia on 30 April 2019. The format included expert speaker presentations, a panel discussion, Q&A sessions and case study workgroup discussions. Participants included regulators, clinicians, pharmacists, academics and healthcare professionals from Colombia who are involved in biological/ biosimilar medicines evaluation, and expert speakers from Canada, Europe and the US. Results: Presentations and topics of discussion included the current status of biosimilars regulation in Colombia, how to carry out a quality assessment of a biological/biosimilar, pharmacological and clinical studies, and extrapolation of indications. Conclusion: The meeting helped to clarify many regulatory concepts and concerns, and highlighted Colombia’s initial successes since the implementation of its regulatory guidelines. In addition, the meeting acted as a forum to exchange knowledge on best practice, and to discuss pharmacovigilance and the future plans for education regarding biosimilars in Colombia. Several key action points were concluded following the discussions.

scholarly journals Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society

2018 ◽  
Vol 1 (2) ◽  
pp. 27-36 ◽  
Author(s):  
Hongyu Zhang ◽  
Mi Deng ◽  
Peng Lin ◽  
Junjian Liu ◽  
Cheng Liu ◽  
...  
Keyword(s):  
Clinical Trials ◽  
T Cell ◽  
T Cell Receptor ◽  
Panel Discussion ◽  
Cell Receptor ◽  
Current Status ◽  
Therapeutic Drug ◽  
Official Journal ◽  
Annual Conference ◽  
Therapeutic Antibodies

ABSTRACT The Chinese Antibody Society (CAS) convened the second annual conference in Cambridge, MA, USA on 29 April 2018. More than 600 members from around the world attended the meeting. Invited speakers discussed the latest advancements in therapeutic antibodies with an emphasis on the progress made in China. The meeting covered a vast variety of topics including the current status of therapeutic antibodies, the progress of immuno-oncology, and biosimilars in China. The conference presentations also included the development of several novel antibodies such as antibodies related to weight loss, T-cell receptor-mimicking antibodies that target intracellular antigens, and tumor-targeting antibodies that utilize both innate and adaptive immune pathways. At the meeting, the CAS announced the launch of its official journal—Antibody Therapeutics—in collaboration with Oxford University Press. The conference was concluded by a panel discussion on how to bring a therapeutic drug developed in China to the USA for clinical trials. Statement of Significance The CAS convened the second annual conference in Cambridge, MA, USA on 29 April 2018. The meeting covered a variety of topics, including therapeutic antibodies being tested in clinical trials, new antibodies (e.g., programmed cell death protein 1/programmed death-ligand 1 inhibitors) being developed in China, and T-cell receptor-mimicking antibodies that target intracellular antigens.

Current status of special planetary and lunar theories and ephemerides

1966 ◽  
Vol 25 ◽  
pp. 266-267
Author(s):  
R. L. Duncombe
Keyword(s):  
Observational Data ◽  
Current Status ◽  
Numerical Errors

An examination of some specialized lunar and planetary ephemerides has revealed inconsistencies in the adopted planetary masses, the presence of non-gravitational terms, and some outright numerical errors. They should be considered of temporary usefulness only, subject to subsequent amendment as required for the interpretation of observational data.

Current Status of Solid-State X-Ray Systems

1985 ◽  
Vol 43 ◽  
pp. 158-161
Author(s):  
Martin Peckerar ◽  
Anastasios Tousimis
Keyword(s):  
Solid State ◽  
Electric Fields ◽  
Spectral Lines ◽  
Current Status ◽  
Mobile Charge ◽  
Electron Hole ◽  
X Ray ◽  
Sensing Systems ◽  
Transmission Electron ◽  
Electron Microscopes

Solid state x-ray sensing systems have been used for many years in conjunction with scanning and transmission electron microscopes. Such systems conveniently provide users with elemental area maps and quantitative chemical analyses of samples. Improvements on these tools are currently sought in the following areas: sensitivity at longer and shorter x-ray wavelengths and minimization of noise-broadening of spectral lines. In this paper, we review basic limitations and recent advances in each of these areas. Throughout the review, we emphasize the systems nature of the problem. That is. limitations exist not only in the sensor elements but also in the preamplifier/amplifier chain and in the interfaces between these components.Solid state x-ray sensors usually function by way of incident photons creating electron-hole pairs in semiconductor material. This radiation-produced mobile charge is swept into external circuitry by electric fields in the semiconductor bulk.

Electron-deficient boron-based catalysts for C–H bond functionalisation

2021 ◽  
Author(s):  
Yuanhong Ma ◽  
Shao-Jie Lou ◽  
Zhaomin Hou
Keyword(s):  
Review Article ◽  
Current Status ◽  
Comprehensive Overview

This review article provides a comprehensive overview to recognise the current status of electron-deficient boron-based catalysis in C–H functionalisations.

Sign in / Sign up

Export Citation Format

Share Document